Skip to main content

Galera Therapeutics, Inc.

GRTXDelisted Sep 6, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001563577

Galera Therapeutics, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Aug 5, 2026; 36 institutions reported holding it in 13F filings for Q1 2024, worth $1.37M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Galera Therapeutics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of GRTX: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders39133−5
Shares10.5M10.7K10.4M−117.7K (−1.1%)
Value$13.7M$14.0K$18.1M+$4.43M (+32.3%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held Galera Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to GRTX in Q3 2022
InstitutionSharesValue% of portfolio
Susquehanna Fundamental Investments, LLC15,000$26.0K0.00%
Tower Research Capital LLC (TRC)10,232$18.0K0.00%
Group One Trading, L.P.853$1.00K0.00%

Sold out (8)

Institutions that held Galera Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of GRTX in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Crestline Management, LP34,305$45.0K
Millennium Management LLC18,530$24.0K
Virtu Financial LLC14,491$19.0K
Citigroup Inc11,599$15.0K
Simplex Trading, LLC1,729$2.00K
Captrust Financial Advisors1,000$1.00K
FNY Investment Advisers, LLC1,500$1.00K
Advisor Group Holdings, Inc.107$0

Not filed for Q3 2022 yet (1)

Institutions that held Galera Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding GRTX in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Taylor Wealth Management Partners10,700$14.0K